Pharmacy

Several drugmakers have raised prices on hundreds of medications despite agreements with the Trump administration aimed at lowering costs, according to an April 16 NBC News report on an analysis by the Senate Committee on Health, Education, Labor and Pensions. …

Viatris has initiated a nationwide recall of Xanax XR (alprazolam extended-release) tablets due to a manufacturing issue. The recall affects 3-milligram tablets packaged in 60-count bottles under lot number 8177156, with an expiration date of Feb. 28, 2027, according to…

Jordan Propst, PharmD, is stepping into his new role as pharmacy director of outpatient and specialty pharmacy services at Prisma Health with an early focus on immersion — both in people and process. “My top priority is my direct team…

Kenny Yu, PharmD, recently stepped into his role as senior vice president and chief pharmacy officer at New York City-based Mount Sinai Health System with a focus on integration across care settings and within broader health system strategy. At the…

Bowling Green, Ky.-based Med Center Health has partnered to create a specialty pharmacy program in its clinics. The program, in partnership with Boston-based ClearWay Health, will ensure patients with complex and chronic illnesses have equitable access to medications and support,…

Rep. Greg Murphy, MD, R-N.C., has introduced a bill that would require out-of-pocket expenditures for drugs to count toward a patient’s maximum out-of-pocket and deductible. Patients are increasingly getting prescription medications through direct-to-patient platforms that offer lower out-of-pocket costs, especially…

Health systems are seeing measurable returns from pharmacy-led initiatives, including a more than 2% reduction in A1C levels and hundreds of incident fixes and system enhancements, according to executives across the U.S. Pharmacy leaders told Becker’s these gains are being…

Vertical integration across insurers, pharmacy benefit managers, specialty pharmacies and healthcare providers continues to reshape the U.S. drug supply chain, according to a Drug Channels report released April 14. Here are four notes from the report:

The FDA has issued a series of regulatory updates in recent weeks spanning gene therapy, drug approvals, clinical trial oversight and compounding policy, reflecting a broader push to accelerate innovation while tightening compliance. Here are five recent FDA developments: 1.…

The Indiana Board of Pharmacy has rejected a proposed settlement with Muncie, Ind.-based Indiana University Health Ball Memorial Hospital, part of Indianapolis-based Indiana University Health, tied to a drug diversion case, the Indiana Capital Chronicle reported April 14. The agreement…